Aquatic Capital Management LLC Invests $317,000 in Alignment Healthcare, Inc. (NASDAQ:ALHC)

Aquatic Capital Management LLC acquired a new position in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 28,176 shares of the company's stock, valued at approximately $317,000.

Several other institutional investors and hedge funds have also bought and sold shares of ALHC. R Squared Ltd purchased a new position in shares of Alignment Healthcare during the fourth quarter valued at approximately $55,000. RiverPark Advisors LLC bought a new stake in shares of Alignment Healthcare during the 4th quarter valued at about $106,000. Tower Research Capital LLC TRC grew its position in Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock valued at $119,000 after buying an additional 6,286 shares during the period. Ballentine Partners LLC purchased a new stake in shares of Alignment Healthcare in the 4th quarter worth $121,000. Finally, Aigen Investment Management LP purchased a new position in shares of Alignment Healthcare during the 4th quarter valued at about $129,000. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. Bank of America increased their target price on shares of Alignment Healthcare from $15.50 to $18.50 and gave the stock a "buy" rating in a report on Tuesday, March 4th. Stifel Nicolaus raised their price objective on shares of Alignment Healthcare from $18.00 to $23.00 and gave the company a "buy" rating in a research report on Tuesday, April 8th. Barclays upped their target price on shares of Alignment Healthcare from $8.00 to $9.00 and gave the stock an "underweight" rating in a report on Friday, February 28th. Piper Sandler raised their price target on Alignment Healthcare from $14.00 to $21.00 and gave the company an "overweight" rating in a report on Tuesday, March 4th. Finally, Robert W. Baird upped their price objective on Alignment Healthcare from $17.00 to $22.00 and gave the stock an "outperform" rating in a research note on Tuesday, April 15th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $17.17.

Insider Activity at Alignment Healthcare

In other news, CEO John E. Kao sold 90,000 shares of the company's stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $14.23, for a total transaction of $1,280,700.00. Following the transaction, the chief executive officer now owns 2,183,100 shares of the company's stock, valued at approximately $31,065,513. This represents a 3.96 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $13.72, for a total value of $411,600.00. Following the completion of the sale, the president now owns 1,576,097 shares in the company, valued at approximately $21,624,050.84. The trade was a 1.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 2,181,855 shares of company stock worth $35,166,057. Insiders own 6.60% of the company's stock.

Alignment Healthcare Trading Down 1.0 %

NASDAQ ALHC traded down $0.15 during trading hours on Friday, hitting $15.27. 424,406 shares of the company were exchanged, compared to its average volume of 1,821,418. The stock has a market cap of $3.02 billion, a PE ratio of -19.83 and a beta of 1.32. Alignment Healthcare, Inc. has a 52 week low of $6.66 and a 52 week high of $21.06. The stock has a 50-day moving average price of $17.36 and a 200 day moving average price of $14.40. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.12) by $0.07. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The company had revenue of $926.93 million during the quarter, compared to the consensus estimate of $889.83 million. During the same period last year, the company earned ($0.25) earnings per share. Alignment Healthcare's revenue was up 47.5% on a year-over-year basis. Analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.